$0.60 EPS Expected for LHC Group, Inc. (LHCG)

April 26, 2018 - By Graig Alexander

LHC Group, Inc. (NASDAQ:LHCG) LogoInvestors sentiment decreased to 1.15 in 2017 Q4. Its down 0.35, from 1.5 in 2017Q3. It is negative, as 30 investors sold LHC Group, Inc. shares while 56 reduced holdings. 38 funds opened positions while 61 raised stakes. 15.67 million shares or 2.23% more from 15.33 million shares in 2017Q3 were reported.
Blackrock reported 2.45M shares or 0.01% of all its holdings. Ameritas Investment Prns, a Nebraska-based fund reported 1,294 shares. D E Shaw & holds 0.01% of its portfolio in LHC Group, Inc. (NASDAQ:LHCG) for 70,026 shares. Kempen Cap Management Nv has 158,004 shares. Georgia-based Invesco Ltd has invested 0% in LHC Group, Inc. (NASDAQ:LHCG). Point72 Asia (Hong Kong) Limited reported 24 shares stake. Kbc Gru Nv stated it has 0.01% of its portfolio in LHC Group, Inc. (NASDAQ:LHCG). Texas Permanent School Fund holds 10,997 shares. Ny State Common Retirement Fund stated it has 30,604 shares or 0% of all its holdings. 6,487 were reported by Capstone Inv Advsr Limited Liability Company. Boston Advsrs Ltd Liability accumulated 0.01% or 10,165 shares. Strs Ohio reported 14,100 shares. Moreover, Alps Advisors Inc has 0% invested in LHC Group, Inc. (NASDAQ:LHCG) for 7,222 shares. Cypress Mngmt Ltd Limited Liability Company (Wy) holds 0% or 15 shares in its portfolio. Sector Pension Invest Board owns 10,280 shares.

Since March 13, 2018, it had 0 insider buys, and 1 insider sale for $909,824 activity.

Analysts expect LHC Group, Inc. (NASDAQ:LHCG) to report $0.60 EPS on May, 2.They anticipate $0.12 EPS change or 25.00 % from last quarter’s $0.48 EPS. LHCG’s profit would be $18.72M giving it 31.50 P/E if the $0.60 EPS is correct. After having $0.62 EPS previously, LHC Group, Inc.’s analysts see -3.23 % EPS growth. The stock increased 0.05% or $0.04 during the last trading session, reaching $75.59. About 179,212 shares traded. LHC Group, Inc. (NASDAQ:LHCG) has risen 15.17% since April 26, 2017 and is uptrending. It has outperformed by 3.62% the S&P500.

LHC Group, Inc. (NASDAQ:LHCG) Ratings Coverage

Among 8 analysts covering LHC Group (NASDAQ:LHCG), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. LHC Group had 12 analyst reports since November 2, 2017 according to SRatingsIntel. The stock of LHC Group, Inc. (NASDAQ:LHCG) earned “Buy” rating by Craig Hallum on Tuesday, November 7. The company was maintained on Wednesday, April 4 by Craig Hallum. The stock has “Hold” rating by Robert W. Baird on Monday, November 27. On Tuesday, April 17 the stock rating was maintained by SunTrust with “Buy”. The company was maintained on Tuesday, November 7 by Oppenheimer. On Thursday, March 1 the stock rating was maintained by Stephens with “Buy”. William Blair maintained LHC Group, Inc. (NASDAQ:LHCG) on Tuesday, January 23 with “Buy” rating. The stock of LHC Group, Inc. (NASDAQ:LHCG) has “Buy” rating given on Tuesday, November 7 by RBC Capital Markets. Oppenheimer maintained it with “Outperform” rating and $85 target in Friday, November 17 report. Jefferies maintained LHC Group, Inc. (NASDAQ:LHCG) on Thursday, November 2 with “Buy” rating.

LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company has market cap of $2.36 billion. The firm operates through four divisions: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. It has a 27.09 P/E ratio. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

LHC Group, Inc. (NASDAQ:LHCG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.